A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin

2017 ◽  
Vol 235 ◽  
pp. 49-55 ◽  
Author(s):  
Dan Ran ◽  
Hui-juan Nie ◽  
Yu-lin Gao ◽  
Song-bai Deng ◽  
Jian-lin Du ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document